Dronabinol effective in reducing neuropathic pain in multiple sclerosis after 48-week treatment
How to Cite
OrthoEvidence. Dronabinol effective in reducing neuropathic pain in multiple sclerosis after 48-week treatment. ACE Report. 2018;7(8):17. Available from: https://myorthoevidene.com/AceReport/Report/10576
Dronabinol is a safe long-term treatment option for neuropathic pain patientsEur Neurol. 2017;78(5-6):320-329.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
240 patients who had neuropathic pain that was associated with multiple sclerosis (MS) were randomly assigned to receive either dronabinol 7.5-15.0 mg daily for 16 weeks, or its respective placebo with the identical schedule. No significant differences in pain reduction and quality of life improvement were found in patients that received dronabinol compared to those that received placebo. In a fol...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE